Janet Rose Rea
Operationeel Directeur bij Ave Maria Biotechnology LLC
Profiel
Janet Rose Rea is currently the Chief Operating Officer at Ave Maria Biotechnology LLC.
Previously, she worked as the VP-Regulatory Affairs, Quality & Clinical Affairs at Atossa Therapeutics, Inc. from 2015 to 2020.
She also served as an Assistant Clinical Professor at the University of Washington.
Ms. Rea completed her undergraduate and graduate degrees at the University of Washington.
Actieve functies van Janet Rose Rea
Bedrijven | Functie | Begin |
---|---|---|
Ave Maria Biotechnology LLC
Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Operationeel Directeur | 08-07-2020 |
Eerdere bekende functies van Janet Rose Rea
Bedrijven | Functie | Einde |
---|---|---|
ATOSSA THERAPEUTICS, INC. | Algemeen Adviseur | 01-07-2020 |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Opleiding van Janet Rose Rea
University of Washington | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ATOSSA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Ave Maria Biotechnology LLC
Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Commercial Services |